• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Real Estate·KBH
Held by 1 Guru
Share

KB Home Stocks

$ 47.05Last Updated 23.10.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

$ 2.86B

$ 47.05
Key Takeaways

Risk factor

Strong trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Decent dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

In Guru Portfolios

Kenneth Griffin

Portfolio Weight (%)

0.0%

Change

+0.00%

Fund

CITADEL ADVISORS LLC

Manager
Fund
Portfolio Weight (%)
Change
Kenneth GriffinCITADEL ADVISORS LLC0.0%+0.00%

Latest news

23.09.2026 15:54

Morning in New York: Diplomacy Will Set the Tone for Trading

25.03.2026 15:34

Morning in New York: geopolitics swaying quotations

19.12.2025 15:35

New York morning: 'witching days' provoke turbulence

17.09.2025 19:41

Barron's picks eight small caps set to 'pop' on Fed rate cut

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

KB Home functions as a prominent residential construction enterprise across the United States. Its operations are strategically divided into four key geographical areas: the West Coast, Southwest, Central, and Southeast regions. The company is engaged in both constructing and selling a wide range of housing types, from attached and detached single-family dwellings to multi-family options like townhouses and condominiums. It serves a diverse clientele, including individuals purchasing their first home, those seeking their first or second upgrade, and active adult homebuyers. Beyond its core building activities, KB Home also extends financial services, offering products such as insurance and title processing. Its operational reach spans numerous states, including Arizona, California, Colorado, Florida, Nevada, North Carolina, Texas, and Washington. Founded in 1957, the company was initially known as Kaufman and Broad Home Corporation before officially adopting the name KB Home in January 2001, with its corporate headquarters located in Los Angeles, California.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on EV/EBIT

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of KBH is 50.7 and suggests 7.76% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

26.10.2026 22:15

Revolut has begun offering consumer loans in the U.K. What does this mean for the company?

26.10.2026 21:31

Tesla shares surged: Barclays advised buying them ahead of the merger with SpaceX

26.10.2026 21:09

"We Decided Not to Delay": What Analysts Are Saying About Anthropic's IPO Prospectus

26.10.2026 19:24

Highlights from Anthropic's prospectus—one of the most anticipated IPOs of the year: online

26.10.2026 19:13

Aardvark sinks 65% on data from halted trial of hunger drug; FDA to allow new tests

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026